• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Ruiqing, YANG Wenqian, YU Yubing, TU Jiasheng, SUN Yixin. Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4[J]. Journal of China Pharmaceutical University, 2018, 49(4): 427-432. DOI: 10.11665/j.issn.1000-5048.20180407
Citation: ZHANG Ruiqing, YANG Wenqian, YU Yubing, TU Jiasheng, SUN Yixin. Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4[J]. Journal of China Pharmaceutical University, 2018, 49(4): 427-432. DOI: 10.11665/j.issn.1000-5048.20180407
shu

Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4

More Information
    Graphical Abstract
    • Abstract
  • To conduct the characterization of its pharmacokinetics in rats of nifedipine sustained-release pellets and to study the relationship between the pellets and CYP3A4 activity. A gradient HPLC method was developed to simultaneously determine 6β-hydroxycortisol and hydrocortisone. CYP3A4 activity of rats was quantified by urinary ratio of 6β-hydroxycortisol/hydrocortisone after intravenous injection of hydrocortisone as a biomarker. HPLC method was also developed to quantify the drug concentration in plasma of rats, and the studies of pharmacokinetics were performed after oral administration of single dose of two formulations: Nifedipine matrix sustained-release pellets and nifedipine tablet(using as control). The results showed that the ratio of ten rats was 0. 271±0. 129. cmax of nifedipine sustained-release pellets decreases by nearly 70%, tmax significantly increased by 400% and t1/2 and MRT significantly increased by 230% compared to control. Nifedipine sustained-release pellets had a significant sustained-release property compared to the control and CYP3A4 activity affected its pharmacokinetics behavior.
    • FullText(HTML)
    • References (15)
  • [1]
    He Q,Yang J.Development of digital gastrointestinal model and its application in absorption prediction of nifedipine sustained-release tablets[J].J China Pharm Univ(中国药科大学学报),2012,43(1):85-91.
    [2]
    Foster TS,Hamann SR,Richards VR,et al.Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects[J].J Clin Pharmacol,1983,23(4):161-170.
    [3]
    Raemsch KD, Sommer J. Pharmacokinetics and metabolism of nifedipine[J] Hypertension,1983,5(4 Pt 2):18-24.
    [4]
    Horster FADB.Clinical investigations on the pharmacokinetics of radioactively marked 4-(2′nitrophenyl)-2,6-dimethyl-1,4-dihydropydine-3,5-dicarboxylic acid dimethrl ester[J].Arzneimittel-Forsch,1972,22:330-334.
    [5]
    Xie SS,Jing XY,Liu XD.Role of intestinal cytochrome P450s in drug metabolism[J].J China Pharm Univ(中国药科大学学报),2010,41(2):186-192.
    [6]
    De Wildt SN,Kearns GL,Leeder JS,et al.Cytochrome P450 3A:ontogeny and drug disposition[J].Clin Pharmacokinet,1999,37(6):485-505.
    [7]
    Kearns GL,Robinson PK,Wilson JT,et al.Cisapride disposition in neonates and infants:in vivo reflection of cytochrome P450 3A4 ontogeny[J].Clin Pharmacol Ther,2003,74(4):312-325.
    [8]
    Chiou WL,Jeong HY,Wu TC,et al.Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization[J].Clin Pharmacol Ther,2001,70(4):305-310.
    [9]
    Tateishi T, Watanabe M, Nakura H, et al. CYP3A activity in European American and Japanese men using midazolam as an in vivo probe[J].Clin Pharmacol Ther,2001,69(5):333-339.
    [10]
    Yamamoto N, Tamura T, Kamiya Y, et al. Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol[J].J Clin Oncol,2000,18(11):2301.
    [11]
    Yu YB,Tu JS.Preparation and comparison of two types of nifedipine sustained-release pellets[J].Pharm Clin Res,2010,18(3):235-238.
    [12]
    Zhang SG,Chen ML,Tang YN.Determination of urinary hydrocortisone and 6β-hydroxycortisol by HPLC[J].Chin J Hosp Pharm(中国医院药学杂志),2004,24(012):733-735.
    [13]
    Suzuki H,Fujiwara S,Kondo S,et al.Determination of nifedipine in human plasma by high-performance liquid chromatography with electrochemical detection[J].J Chromatogr B Biomed Sci Appl,1985,341:341-347.
    [14]
    Yritia M,Parra P,Iglesias E,et al.Quantitation of nifedipine in human plasma by on-line solid-phase extraction and high-performance liquid chromatography[J].J Chromatogr A,2000,870(1/2):115-119.
    [15]
    Hang TJ,Zhang L.Relative bioavailability and pharmacokinetics of two oral nifedipine sustained-release capsules in Chinese volunteers after single dose administration[J].Chin J Med Chemistry(中国药学杂志),2000,35(10):681-683.
    • Related Articles

  • Related Articles

    [1]CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002
    [2]JIANG Xiaomei, LIU Chong. Neuroprotective effect of glycyrrhizin on diabetic retinopathy[J]. Journal of China Pharmaceutical University, 2020, 51(6): 711-717. DOI: 10.11665/j.issn.1000-5048.20200610
    [3]MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316
    [4]TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315
    [5]YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105
    [6]TANG Qian, CHEN Song, GAO Xiangdong. Advances of mechanisms of metabolic memory-based diabetic complications and therapeutic drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 622-628. DOI: 10.11665/j.issn.1000-5048.20170519
    [7]HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
    [8]WANG Xin-ting, ZHANG Mian, GUO Hai-fang, LIU Can, HU Nan, LIU Li, LIU Xiao-dong. Effect and mechanism of atorvastatin on blood glucose of mild diabetic rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 453-459.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]PREVENTION AND TREATMENT OF ALLOXAN-INDUCED DIABETES IN MICE BY POLYSACCHARIDES FROM SPORE OF TREMELLA FUCIFORMIS BERK[J]. Journal of China Pharmaceutical University, 1988, (4): 303-304.

  • Cited by

    Periodical cited type(2)

    1. 林会平，孙国绍，梁波. 两种7-羟基香豆素衍生物的合成和NMR分析. 广州化学. 2020(01): 31-37 .
    2. 雷志伟，尹荣秀，李露露，郭灿. 香豆素类化合物合成的研究概况. 贵州茶叶. 2019(03): 18-21 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (1270) PDF downloads (1560) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：302641

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return